• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    CNS Pharmaceuticals, Inc. - Common Stock (NQ: CNSP )

    0.1149 UNCHANGED
    Streaming Delayed Price Updated: 4:00 PM EST, Dec 26, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Press Releases about CNS Pharmaceuticals, Inc. - Common Stock

    < Previous 1 2 3 4 5 6 7 8 9
    ...
    11 12 Next >
    Research Shows Brain Tumors Grow by Hijacking Circadian Clocks
    Via Investor Brand Network
    BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) to Host Virtual Analyst & Investor Day on December 11
    Via Investor Brand Network
    CNS Pharmaceuticals to Host Virtual Analyst & Investor Day on December 11, 2024
    Via ACCESSWIRE
    AI Model Promises New Way to Detect Brain Malignancies
    Via Investor Brand Network
    Topics Artificial Intelligence Death
    Exposures Artificial Intelligence Death
    BioMedNewsBreaks — CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Presents Progress in Pivotal Study of Berubicin for Glioblastoma Treatment
    Via Investor Brand Network
    Exposures Product Safety
    CNS Pharmaceuticals Reports Third Quarter 2024 Financial Results
    Via ACCESSWIRE
    New Graphene Chip Could Revolutionize Brain Cancer Treatment
    Via Investor Brand Network
    CNS Pharmaceuticals Announces Virtual Investor KOL Connect Segment
    Via ACCESSWIRE
    CNS Pharmaceuticals Presents Update from Ongoing Potentially Pivotal Study of Berubicin Compared with Lomustine in Adult Patients with Recurrent GBM (WHO Grade IV) After Failure of Standard First Line Therapy
    Via ACCESSWIRE
    BioMedNewsBreaks — CNS Pharmaceuticals Inc. (NASDAQ: CNSP) to Present Berubicin Trial Update at Society for Neuro-Oncology Annual Meeting
    Via Investor Brand Network
    CNS Pharmaceuticals Announces Abstract Accepted for Poster Presentation at the 29th Annual Meeting of the Society for Neuro-Oncology (SNO 2024)
    Via ACCESSWIRE
    BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Advances Glioblastoma Treatment with Berubicin Amid Strong Financial Position
    Via Investor Brand Network
    Exposures Product Safety
    CNS Pharmaceuticals Participates in Virtual Investor KOL Connect Segment
    Via ACCESSWIRE
    CNS Pharmaceuticals to Participate in the 2024 Healthcare Virtual Summit Presented by Maxim Group LLC
    Via ACCESSWIRE
    CNS Pharmaceuticals to Present at the 24th Annual Biotech in Europe Forum
    Via ACCESSWIRE
    BioMedNewsBreaks — CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Highlights Berubicin’s Potential in Glioblastoma Treatment During KOL Connect Event
    Via Investor Brand Network
    BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Granted Nasdaq Extension for Compliance
    Via Investor Brand Network
    CNS Pharmaceuticals Granted Exception by Nasdaq to Regain Compliance with Minimum Bid Price Requirement
    Via ACCESSWIRE
    Stocks Under Ten Cents to Watch in October 2024 CNSP, QLGN, AKTS, CBDW, RJDG
    Via AB Newswire
    BioMedNewsBreaks — CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Secures $3 Million in Registered Direct Offering
    Via Investor Brand Network
    CNS Pharmaceuticals Announces Pricing of $3 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules
    Via ACCESSWIRE
    BioMedNewsBreaks — CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Management, Dr. Samuel Goldlust Participate in Virtual Investor KOL Connect Segment
    Via Investor Brand Network
    Jimmy Carter Survival Thanks to Novel Cancer Immunotherapy Treatment
    Via Investor Brand Network
    BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Announces Participation at the 24th Annual Biotech in Europe Forum
    Via Investor Brand Network
    WHO Review Says No Link Between Mobile Phones, Brain-Cancer Development
    Via Investor Brand Network
    CNS Pharmaceuticals Regains Compliance with Nasdaq Equity Requirement
    Via ACCESSWIRE
    BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) CEO Slated to Present at H.C. Wainwright 26th Annual Global Investment Conference
    Via Investor Brand Network
    CNS Pharmaceuticals to Present at the H.C. Wainwright 26th Annual Global Investment Conference
    Via ACCESSWIRE
    BioMedNewsBreaks — CNS Pharmaceuticals Inc. (NASDAQ: CNSP) CEO Featured in Latest BioMedWire Podcast Episode
    Via Investor Brand Network
    BioMedNewsBreaks — CNS Pharmaceuticals Inc. (NASDAQ: CNSP) CEO to Present at LIVE! with Webull Corporate Connect: Virtual Biotech Investment Webinar
    Via Investor Brand Network
    < Previous 1 2 3 4 5 6 7 8 9
    ...
    11 12 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.